Abstract Overview: Commercial PD-1 Inhibitors for Advanced NSCLC Patients - 102164

Spotlight
Video

Abstract Overview: Commercial PD-1 Inhibitors for Advanced NSCLC Patients

Loading........
Description: Mizuki Nishino, MD, MPH of Dana-Farber Cancer Institute gives an overview of her presentation, Tumor response dynamics of advanced non-small-cell lung cancer (NSCLC) patients (pts) treated with commercial PD-1 inhibitors in the clinical setting, which was presented at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 9087: Tumor response dynamics of advanced non-small-cell lung cancer (NSCLC) patients (pts) treated with commercial PD-1 inhibitors in the clinical setting.
Shared By : AnnualMeeting2017
Posted on : 06/04/17
Added : 1 year ago